Polpharma Secures Government Funding For Complex Inhalable And Injectable Generics

One Grant Will Be Used To Develop A Generic Polypeptide

The Polish player has won two grants sourced from the government’s National Recovery and Resilience Plan, which has given out $28.1m in funding in the latest round.

Warsaw capitol of Poland. Copy Space available. - Image
Polish Regulator URPL Has Approved Two Switches • Source: Shutterstock

The drug manufacturer Polpharma has won two grants from the Polish Medical Research Agency aimed at the development of new generics for respiratory diseases and type 2 diabetes.

Specifically, the Polish generic drug maker received a grant for the development of inhalable complex generic drugs for the treatment...

More from Generics

More from Generics Bulletin